A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma

A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma

Su-Ya Hsu,1 Hui-Yuan Yu,2 Wei-Chen Lee,1 Chia-En Hsiao,1 Chih-Lung Wu,1 Hsi-Tsung Cheng,2 Li-Jin Lin,2 Fang Li,3 Yu-Ting Chou,1 Jya-Wei Cheng1 1Department of Medical Science, Institute of Biotechnology, National Tsing Hua University, Hsinchu 300, Taiwan; 2Division of Cancer Research, Rise Biopharmac...

Full description

Bibliographic Details
Main Authors: Hsu SY, Yu HY, Lee WC, Hsiao CE, Wu CL, Cheng HT, Lin LJ, Li F, Chou YT, Cheng JW
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:OncoTargets and Therapy
Subjects:
CXCL8
CXCR1
CXCR2
antagonist
Lewis lung carcinoma.
Online Access:https://www.dovepress.com/a-novel-cxcl8-analog-is-effective-in-inhibiting-the-growth-via-cell-cy-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/a-novel-cxcl8-analog-is-effective-in-inhibiting-the-growth-via-cell-cy-peer-reviewed-article-OTT

Similar Items